Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Cencora Inc COR

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions... see more

Recent & Breaking News (NYSE:COR)

AmerisourceBergen Launches Cell and Gene Therapy Innovation Hub

Business Wire April 24, 2023

TPG and AmerisourceBergen to Acquire Leading Specialty Practice Network OneOncology From General Atlantic

Business Wire April 20, 2023

AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2023 Earnings Release

Business Wire March 29, 2023

AmerisourceBergen Reports Fiscal 2023 First Quarter Results

Business Wire February 1, 2023

AmerisourceBergen Announces Intent to Change Name to Cencora

Business Wire January 24, 2023

AmerisourceBergen Kicks Off Strategic Relationship with Civica

Business Wire January 23, 2023

AmerisourceBergen Announces Date and Time for First Quarter Fiscal 2023 Earnings Release

Business Wire January 3, 2023

AmerisourceBergen Completes Acquisition of PharmaLex

Business Wire January 3, 2023

AmerisourceBergen Announces Common Share Repurchase From Walgreens Boots Alliance

Business Wire December 8, 2022

AmerisourceBergen Elects Redonda Miller, M.D., to its Board of Directors

Business Wire November 16, 2022

Walgreens Boots Alliance Announces Offering of 10 Million Shares of AmerisourceBergen Corporation

Business Wire November 7, 2022

AmerisourceBergen Announces Secondary Public Offering of Common Shares and Common Share Repurchase

Business Wire November 7, 2022

AmerisourceBergen Reports Fiscal 2022 Fourth Quarter and Year End Results

Business Wire November 3, 2022

AmerisourceBergen Announces Date and Time for Fourth Quarter Fiscal 2022 Earnings Release

Business Wire September 28, 2022

AmerisourceBergen Elects Lorence H. Kim, M.D., to Its Board of Directors

Business Wire September 27, 2022

AmerisourceBergen to Expand Global Biopharma Services Platform With Acquisition of PharmaLex

Business Wire September 12, 2022

AmerisourceBergen Reports Fiscal 2022 Third Quarter Results

Business Wire August 3, 2022

AmerisourceBergen Announces Date and Time for Third Quarter Fiscal 2022 Earnings Release

Business Wire June 29, 2022

Seefried Properties Break Ground on New Distribution Facility in Mount Prospect, IL

PR Newswire June 21, 2022

AmerisourceBergen Presents Long-term Vision and Guidance at Investor Day

Business Wire June 1, 2022